Advertisement

Index by author

November 01, 1991; Volume 40,Issue 5

A

  1. Addya, K

    1. Biochemical analysis of solubilized angiotensin II receptors from murine neuroblastoma N1E-115 cells by covalent cross-linking and affinity purification.
      I R Siemens, H J Adler, K Addya, S J Mah and S J Fluharty
      Molecular Pharmacology November 1991, 40 (5) 717-726;

  2. Adler, H J

    1. Biochemical analysis of solubilized angiotensin II receptors from murine neuroblastoma N1E-115 cells by covalent cross-linking and affinity purification.
      I R Siemens, H J Adler, K Addya, S J Mah and S J Fluharty
      Molecular Pharmacology November 1991, 40 (5) 717-726;

  3. Aftab, D T

    1. Structure-activity relationships of phenothiazines and related drugs for inhibition of protein kinase C.
      D T Aftab, L M Ballas, C R Loomis and W N Hait
      Molecular Pharmacology November 1991, 40 (5) 798-805;

B

  1. Ballas, L M

    1. Structure-activity relationships of phenothiazines and related drugs for inhibition of protein kinase C.
      D T Aftab, L M Ballas, C R Loomis and W N Hait
      Molecular Pharmacology November 1991, 40 (5) 798-805;

  2. Bertino, J R

    1. Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.
      W W Li, J T Lin, B I Schweitzer and J R Bertino
      Molecular Pharmacology November 1991, 40 (5) 854-858;

  3. Boobis, A R

    1. Inducible bilirubin-degrading system of rat liver microsomes: role of cytochrome P450IA1.
      F De Matteis, S J Dawson, A R Boobis and A Comoglio
      Molecular Pharmacology November 1991, 40 (5) 686-691;

  4. Boucher, R C

    1. Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells.
      H A Brown, E R Lazarowski, R C Boucher and T K Harden
      Molecular Pharmacology November 1991, 40 (5) 648-655;

  5. Brown, H A

    1. Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells.
      H A Brown, E R Lazarowski, R C Boucher and T K Harden
      Molecular Pharmacology November 1991, 40 (5) 648-655;

C

  1. Caron, M G

    1. The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity.
      D A Schwinn, S O Page, J P Middleton, W Lorenz, S B Liggett, K Yamamoto, E G Lapetina, M G Caron, R J Lefkowitz and S Cotecchia
      Molecular Pharmacology November 1991, 40 (5) 619-626;

  2. Catterall, W A

    1. Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.
      D S Ragsdale, T Scheuer and W A Catterall
      Molecular Pharmacology November 1991, 40 (5) 756-765;

  3. Celentano, J J

    1. Negative modulation of the gamma-aminobutyric acid response by extracellular zinc.
      J J Celentano, M Gyenes, T T Gibbs and D H Farb
      Molecular Pharmacology November 1991, 40 (5) 766-773;

  4. Chae, K

    1. Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity.
      K Chae, M K Gibson and K S Korach
      Molecular Pharmacology November 1991, 40 (5) 806-811;

  5. Comoglio, A

    1. Inducible bilirubin-degrading system of rat liver microsomes: role of cytochrome P450IA1.
      F De Matteis, S J Dawson, A R Boobis and A Comoglio
      Molecular Pharmacology November 1991, 40 (5) 686-691;

  6. Compton, D R

    1. Modeling the cannabinoid receptor: a three-dimensional quantitative structure-activity analysis.
      B F Thomas, D R Compton, B R Martin and S F Semus
      Molecular Pharmacology November 1991, 40 (5) 656-665;

  7. Cotecchia, S

    1. The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity.
      D A Schwinn, S O Page, J P Middleton, W Lorenz, S B Liggett, K Yamamoto, E G Lapetina, M G Caron, R J Lefkowitz and S Cotecchia
      Molecular Pharmacology November 1991, 40 (5) 619-626;

D

  1. David, C

    1. Antipeptide antibodies localize N-(4-azido-3-[125I] iodophenethyl)spiperone binding to the carboxyl-terminal portion of the D2 dopamine receptor.
      C David and S Fuchs
      Molecular Pharmacology November 1991, 40 (5) 712-716;

  2. Dawson, S J

    1. Inducible bilirubin-degrading system of rat liver microsomes: role of cytochrome P450IA1.
      F De Matteis, S J Dawson, A R Boobis and A Comoglio
      Molecular Pharmacology November 1991, 40 (5) 686-691;

  3. Day, R O

    1. Inhibition of DNA binding and transcriptional activity of a nuclear receptor transcription factor by aurothiomalate and other metal ions.
      M L Handel, A deFazio, C K Watts, R O Day and R L Sutherland
      Molecular Pharmacology November 1991, 40 (5) 613-618;

  4. deFazio, A

    1. Inhibition of DNA binding and transcriptional activity of a nuclear receptor transcription factor by aurothiomalate and other metal ions.
      M L Handel, A deFazio, C K Watts, R O Day and R L Sutherland
      Molecular Pharmacology November 1991, 40 (5) 613-618;

  5. De Matteis, F

    1. Inducible bilirubin-degrading system of rat liver microsomes: role of cytochrome P450IA1.
      F De Matteis, S J Dawson, A R Boobis and A Comoglio
      Molecular Pharmacology November 1991, 40 (5) 686-691;

  6. Denison, M S

    1. Ultraviolet photoproducts of tryptophan can act as dioxin agonists.
      W G Helferich and M S Denison
      Molecular Pharmacology November 1991, 40 (5) 674-678;

  7. Diamond, I

    1. cAMP-dependent protein kinase regulates inhibition of adenosine transport by ethanol.
      L E Nagy, I Diamond and A S Gordon
      Molecular Pharmacology November 1991, 40 (5) 812-817;

E

  1. Eberhart, D C

    1. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
      D C Eberhart, B Gemzik, M R Halvorson and A Parkinson
      Molecular Pharmacology November 1991, 40 (5) 859-867;

F

  1. Farb, D H

    1. Negative modulation of the gamma-aminobutyric acid response by extracellular zinc.
      J J Celentano, M Gyenes, T T Gibbs and D H Farb
      Molecular Pharmacology November 1991, 40 (5) 766-773;

  2. Fischer, V

    1. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis.
      V Fischer, J A Haar, L Greiner, R V Lloyd and R P Mason
      Molecular Pharmacology November 1991, 40 (5) 846-853;

  3. Fluharty, S J

    1. Biochemical analysis of solubilized angiotensin II receptors from murine neuroblastoma N1E-115 cells by covalent cross-linking and affinity purification.
      I R Siemens, H J Adler, K Addya, S J Mah and S J Fluharty
      Molecular Pharmacology November 1991, 40 (5) 717-726;

  4. Fuchs, S

    1. Antipeptide antibodies localize N-(4-azido-3-[125I] iodophenethyl)spiperone binding to the carboxyl-terminal portion of the D2 dopamine receptor.
      C David and S Fuchs
      Molecular Pharmacology November 1991, 40 (5) 712-716;

  5. Fujita, T

    1. Trichosporin-B-III, an alpha-aminoisobutyric acid-containing peptide, causes Ca(2+)-dependent catecholamine secretion from adrenal medullary chromaffin cells.
      E Tachikawa, S Takahashi, K Furumachi, T Kashimoto, A Iida, Y Nagaoka, T Fujita and Y Takaishi
      Molecular Pharmacology November 1991, 40 (5) 790-797;

  6. Furumachi, K

    1. Trichosporin-B-III, an alpha-aminoisobutyric acid-containing peptide, causes Ca(2+)-dependent catecholamine secretion from adrenal medullary chromaffin cells.
      E Tachikawa, S Takahashi, K Furumachi, T Kashimoto, A Iida, Y Nagaoka, T Fujita and Y Takaishi
      Molecular Pharmacology November 1991, 40 (5) 790-797;

G

  1. Gasiewicz, T A

    1. Alpha-naphthoflavone acts as an antagonist of 2,3,7, 8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor.
      T A Gasiewicz and G Rucci
      Molecular Pharmacology November 1991, 40 (5) 607-612;

  2. Gemzik, B

    1. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
      D C Eberhart, B Gemzik, M R Halvorson and A Parkinson
      Molecular Pharmacology November 1991, 40 (5) 859-867;

  3. Gerhardt, M A

    1. Multiple Gi protein subtypes regulate a single effector mechanism.
      M A Gerhardt and R R Neubig
      Molecular Pharmacology November 1991, 40 (5) 707-711;

  4. Gibbs, T T

    1. Negative modulation of the gamma-aminobutyric acid response by extracellular zinc.
      J J Celentano, M Gyenes, T T Gibbs and D H Farb
      Molecular Pharmacology November 1991, 40 (5) 766-773;

  5. Gibson, M K

    1. Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity.
      K Chae, M K Gibson and K S Korach
      Molecular Pharmacology November 1991, 40 (5) 806-811;

  6. Giorgi-Renault, S

    1. Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives.
      J F Riou, P Helissey, L Grondard and S Giorgi-Renault
      Molecular Pharmacology November 1991, 40 (5) 699-706;

  7. Golas, C L

    1. Ah receptor in mice genetically "nonresponsive" for cytochrome P4501A1 induction: cytosolic Ah receptor, transformation to the nuclear binding state, and induction of aryl hydrocarbon hydroxylase by halogenated and nonhalogenated aromatic hydrocarbons in embryonic tissues and cells.
      P A Harper, C L Golas and A B Okey
      Molecular Pharmacology November 1991, 40 (5) 818-826;

  8. Gordon, A S

    1. cAMP-dependent protein kinase regulates inhibition of adenosine transport by ethanol.
      L E Nagy, I Diamond and A S Gordon
      Molecular Pharmacology November 1991, 40 (5) 812-817;

  9. Greiner, L

    1. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis.
      V Fischer, J A Haar, L Greiner, R V Lloyd and R P Mason
      Molecular Pharmacology November 1991, 40 (5) 846-853;

  10. Grondard, L

    1. Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives.
      J F Riou, P Helissey, L Grondard and S Giorgi-Renault
      Molecular Pharmacology November 1991, 40 (5) 699-706;

  11. Guengerich, F P

    1. Purification and characterization of human liver microsomal cytochrome P-450 2A6.
      C H Yun, T Shimada and F P Guengerich
      Molecular Pharmacology November 1991, 40 (5) 679-685;

  12. Gusovsky, F

    1. Prostaglandin receptors in NIH 3T3 cells: coupling of one receptor to adenylate cyclase and of a second receptor to phospholipase C.
      F Gusovsky
      Molecular Pharmacology November 1991, 40 (5) 633-638;

  13. Gyenes, M

    1. Negative modulation of the gamma-aminobutyric acid response by extracellular zinc.
      J J Celentano, M Gyenes, T T Gibbs and D H Farb
      Molecular Pharmacology November 1991, 40 (5) 766-773;

H

  1. Haar, J A

    1. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis.
      V Fischer, J A Haar, L Greiner, R V Lloyd and R P Mason
      Molecular Pharmacology November 1991, 40 (5) 846-853;

  2. Hait, W N

    1. Structure-activity relationships of phenothiazines and related drugs for inhibition of protein kinase C.
      D T Aftab, L M Ballas, C R Loomis and W N Hait
      Molecular Pharmacology November 1991, 40 (5) 798-805;

  3. Halvorson, M R

    1. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
      D C Eberhart, B Gemzik, M R Halvorson and A Parkinson
      Molecular Pharmacology November 1991, 40 (5) 859-867;

  4. Hamel, E

    1. Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)-one.
      C M Lin, G J Kang, M C Roach, J B Jiang, D P Hesson, R F Luduena and E Hamel
      Molecular Pharmacology November 1991, 40 (5) 827-832;

  5. Handel, M L

    1. Inhibition of DNA binding and transcriptional activity of a nuclear receptor transcription factor by aurothiomalate and other metal ions.
      M L Handel, A deFazio, C K Watts, R O Day and R L Sutherland
      Molecular Pharmacology November 1991, 40 (5) 613-618;

  6. Hanna, J L

    1. Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines.
      K Williams, J L Hanna and P B Molinoff
      Molecular Pharmacology November 1991, 40 (5) 774-782;

  7. Harden, T K

    1. Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells.
      H A Brown, E R Lazarowski, R C Boucher and T K Harden
      Molecular Pharmacology November 1991, 40 (5) 648-655;

  8. Haring, R

    1. High efficiency reconstitution of a phencyclidine/MK-801 receptor binding site solubilized from rat forebrain membranes.
      R Haring, D E Pellegrini-Giampietro, S R Zukin, R S Zukin and M A Scheideler
      Molecular Pharmacology November 1991, 40 (5) 666-673;

  9. Harper, P A

    1. Ah receptor in mice genetically "nonresponsive" for cytochrome P4501A1 induction: cytosolic Ah receptor, transformation to the nuclear binding state, and induction of aryl hydrocarbon hydroxylase by halogenated and nonhalogenated aromatic hydrocarbons in embryonic tissues and cells.
      P A Harper, C L Golas and A B Okey
      Molecular Pharmacology November 1991, 40 (5) 818-826;

  10. Helferich, W G

    1. Ultraviolet photoproducts of tryptophan can act as dioxin agonists.
      W G Helferich and M S Denison
      Molecular Pharmacology November 1991, 40 (5) 674-678;

  11. Helissey, P

    1. Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives.
      J F Riou, P Helissey, L Grondard and S Giorgi-Renault
      Molecular Pharmacology November 1991, 40 (5) 699-706;

  12. Hesson, D P

    1. Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)-one.
      C M Lin, G J Kang, M C Roach, J B Jiang, D P Hesson, R F Luduena and E Hamel
      Molecular Pharmacology November 1991, 40 (5) 827-832;

  13. Hirning, L D

    1. omega-Conotoxin exerts functionally distinct low and high affinity effects in the neuronal cell line NG108-15.
      J L Werth, L D Hirning and S A Thayer
      Molecular Pharmacology November 1991, 40 (5) 742-749;

  14. Hitchcock, M J

    1. Metabolism and DNA interaction of 2',3'-didehydro-2',3'-dideoxythymidine in human bone marrow cells.
      Z Zhu, M J Hitchcock and J P Sommadossi
      Molecular Pharmacology November 1991, 40 (5) 838-845;

I

  1. Iida, A

    1. Trichosporin-B-III, an alpha-aminoisobutyric acid-containing peptide, causes Ca(2+)-dependent catecholamine secretion from adrenal medullary chromaffin cells.
      E Tachikawa, S Takahashi, K Furumachi, T Kashimoto, A Iida, Y Nagaoka, T Fujita and Y Takaishi
      Molecular Pharmacology November 1991, 40 (5) 790-797;

J

  1. Jacobson, K A

    1. Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.
      V Ramkumar, M E Olah, K A Jacobson and G L Stiles
      Molecular Pharmacology November 1991, 40 (5) 639-647;

  2. Jiang, J B

    1. Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)-one.
      C M Lin, G J Kang, M C Roach, J B Jiang, D P Hesson, R F Luduena and E Hamel
      Molecular Pharmacology November 1991, 40 (5) 827-832;

  3. Johnson, E F

    1. Properties of expressed and native flavin-containing monooxygenases: evidence of multiple forms in rabbit liver and lung.
      M P Lawton, T Kronbach, E F Johnson and R M Philpot
      Molecular Pharmacology November 1991, 40 (5) 692-698;

K

  1. Kang, G J

    1. Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)-one.
      C M Lin, G J Kang, M C Roach, J B Jiang, D P Hesson, R F Luduena and E Hamel
      Molecular Pharmacology November 1991, 40 (5) 827-832;

  2. Kashimoto, T

    1. Trichosporin-B-III, an alpha-aminoisobutyric acid-containing peptide, causes Ca(2+)-dependent catecholamine secretion from adrenal medullary chromaffin cells.
      E Tachikawa, S Takahashi, K Furumachi, T Kashimoto, A Iida, Y Nagaoka, T Fujita and Y Takaishi
      Molecular Pharmacology November 1991, 40 (5) 790-797;

  3. Korach, K S

    1. Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity.
      K Chae, M K Gibson and K S Korach
      Molecular Pharmacology November 1991, 40 (5) 806-811;

  4. Kronbach, T

    1. Properties of expressed and native flavin-containing monooxygenases: evidence of multiple forms in rabbit liver and lung.
      M P Lawton, T Kronbach, E F Johnson and R M Philpot
      Molecular Pharmacology November 1991, 40 (5) 692-698;

  5. Kulmacz, R J

    1. Prostaglandin H synthase: perturbation of the tyrosyl radical as a probe of anticyclooxygenase agents.
      R J Kulmacz, G Palmer and A L Tsai
      Molecular Pharmacology November 1991, 40 (5) 833-837;

L

  1. Lapetina, E G

    1. The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity.
      D A Schwinn, S O Page, J P Middleton, W Lorenz, S B Liggett, K Yamamoto, E G Lapetina, M G Caron, R J Lefkowitz and S Cotecchia
      Molecular Pharmacology November 1991, 40 (5) 619-626;

  2. Lawton, M P

    1. Properties of expressed and native flavin-containing monooxygenases: evidence of multiple forms in rabbit liver and lung.
      M P Lawton, T Kronbach, E F Johnson and R M Philpot
      Molecular Pharmacology November 1991, 40 (5) 692-698;

  3. Lazarowski, E R

    1. Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells.
      H A Brown, E R Lazarowski, R C Boucher and T K Harden
      Molecular Pharmacology November 1991, 40 (5) 648-655;

  4. Lefkowitz, R J

    1. The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity.
      D A Schwinn, S O Page, J P Middleton, W Lorenz, S B Liggett, K Yamamoto, E G Lapetina, M G Caron, R J Lefkowitz and S Cotecchia
      Molecular Pharmacology November 1991, 40 (5) 619-626;

  5. Li, M

    1. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines.
      S J Wall, R P Yasuda, M Li and B B Wolfe
      Molecular Pharmacology November 1991, 40 (5) 783-789;

  6. Li, W W

    1. Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.
      W W Li, J T Lin, B I Schweitzer and J R Bertino
      Molecular Pharmacology November 1991, 40 (5) 854-858;

  7. Liggett, S B

    1. The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity.
      D A Schwinn, S O Page, J P Middleton, W Lorenz, S B Liggett, K Yamamoto, E G Lapetina, M G Caron, R J Lefkowitz and S Cotecchia
      Molecular Pharmacology November 1991, 40 (5) 619-626;

  8. Lin, C M

    1. Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)-one.
      C M Lin, G J Kang, M C Roach, J B Jiang, D P Hesson, R F Luduena and E Hamel
      Molecular Pharmacology November 1991, 40 (5) 827-832;

  9. Lin, J T

    1. Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.
      W W Li, J T Lin, B I Schweitzer and J R Bertino
      Molecular Pharmacology November 1991, 40 (5) 854-858;

  10. Lloyd, R V

    1. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis.
      V Fischer, J A Haar, L Greiner, R V Lloyd and R P Mason
      Molecular Pharmacology November 1991, 40 (5) 846-853;

  11. Loomis, C R

    1. Structure-activity relationships of phenothiazines and related drugs for inhibition of protein kinase C.
      D T Aftab, L M Ballas, C R Loomis and W N Hait
      Molecular Pharmacology November 1991, 40 (5) 798-805;

  12. Lorenz, W

    1. The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity.
      D A Schwinn, S O Page, J P Middleton, W Lorenz, S B Liggett, K Yamamoto, E G Lapetina, M G Caron, R J Lefkowitz and S Cotecchia
      Molecular Pharmacology November 1991, 40 (5) 619-626;

  13. Luduena, R F

    1. Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)-one.
      C M Lin, G J Kang, M C Roach, J B Jiang, D P Hesson, R F Luduena and E Hamel
      Molecular Pharmacology November 1991, 40 (5) 827-832;

M

  1. Mah, S J

    1. Biochemical analysis of solubilized angiotensin II receptors from murine neuroblastoma N1E-115 cells by covalent cross-linking and affinity purification.
      I R Siemens, H J Adler, K Addya, S J Mah and S J Fluharty
      Molecular Pharmacology November 1991, 40 (5) 717-726;

  2. Martin, B R

    1. Modeling the cannabinoid receptor: a three-dimensional quantitative structure-activity analysis.
      B F Thomas, D R Compton, B R Martin and S F Semus
      Molecular Pharmacology November 1991, 40 (5) 656-665;

  3. Mason, R P

    1. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis.
      V Fischer, J A Haar, L Greiner, R V Lloyd and R P Mason
      Molecular Pharmacology November 1991, 40 (5) 846-853;

  4. McClue, S J

    1. Molecular interaction of the human alpha 2-C10-adrenergic receptor, when expressed in Rat-1 fibroblasts, with multiple pertussis toxin-sensitive guanine nucleotide-binding proteins: studies with site-directed antisera.
      S J McClue and G Milligan
      Molecular Pharmacology November 1991, 40 (5) 627-632;

  5. Menniti, F S

    1. Different modes of regulation for receptors activating phospholipase C in the rat pancreatoma cell line AR4-2J.
      F S Menniti, H Takemura, K G Oliver and J W Putney
      Molecular Pharmacology November 1991, 40 (5) 727-733;

  6. Middleton, J P

    1. The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity.
      D A Schwinn, S O Page, J P Middleton, W Lorenz, S B Liggett, K Yamamoto, E G Lapetina, M G Caron, R J Lefkowitz and S Cotecchia
      Molecular Pharmacology November 1991, 40 (5) 619-626;

  7. Milligan, G

    1. Molecular interaction of the human alpha 2-C10-adrenergic receptor, when expressed in Rat-1 fibroblasts, with multiple pertussis toxin-sensitive guanine nucleotide-binding proteins: studies with site-directed antisera.
      S J McClue and G Milligan
      Molecular Pharmacology November 1991, 40 (5) 627-632;

  8. Molinoff, P B

    1. Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines.
      K Williams, J L Hanna and P B Molinoff
      Molecular Pharmacology November 1991, 40 (5) 774-782;

N

  1. Nagaoka, Y

    1. Trichosporin-B-III, an alpha-aminoisobutyric acid-containing peptide, causes Ca(2+)-dependent catecholamine secretion from adrenal medullary chromaffin cells.
      E Tachikawa, S Takahashi, K Furumachi, T Kashimoto, A Iida, Y Nagaoka, T Fujita and Y Takaishi
      Molecular Pharmacology November 1991, 40 (5) 790-797;

  2. Nagy, L E

    1. cAMP-dependent protein kinase regulates inhibition of adenosine transport by ethanol.
      L E Nagy, I Diamond and A S Gordon
      Molecular Pharmacology November 1991, 40 (5) 812-817;

  3. Neubig, R R

    1. Multiple Gi protein subtypes regulate a single effector mechanism.
      M A Gerhardt and R R Neubig
      Molecular Pharmacology November 1991, 40 (5) 707-711;

O

  1. Okey, A B

    1. Ah receptor in mice genetically "nonresponsive" for cytochrome P4501A1 induction: cytosolic Ah receptor, transformation to the nuclear binding state, and induction of aryl hydrocarbon hydroxylase by halogenated and nonhalogenated aromatic hydrocarbons in embryonic tissues and cells.
      P A Harper, C L Golas and A B Okey
      Molecular Pharmacology November 1991, 40 (5) 818-826;

  2. Olah, M E

    1. Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.
      V Ramkumar, M E Olah, K A Jacobson and G L Stiles
      Molecular Pharmacology November 1991, 40 (5) 639-647;

  3. Oliver, K G

    1. Different modes of regulation for receptors activating phospholipase C in the rat pancreatoma cell line AR4-2J.
      F S Menniti, H Takemura, K G Oliver and J W Putney
      Molecular Pharmacology November 1991, 40 (5) 727-733;

P

  1. Page, S O

    1. The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity.
      D A Schwinn, S O Page, J P Middleton, W Lorenz, S B Liggett, K Yamamoto, E G Lapetina, M G Caron, R J Lefkowitz and S Cotecchia
      Molecular Pharmacology November 1991, 40 (5) 619-626;

  2. Palmer, G

    1. Prostaglandin H synthase: perturbation of the tyrosyl radical as a probe of anticyclooxygenase agents.
      R J Kulmacz, G Palmer and A L Tsai
      Molecular Pharmacology November 1991, 40 (5) 833-837;

  3. Parkinson, A

    1. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
      D C Eberhart, B Gemzik, M R Halvorson and A Parkinson
      Molecular Pharmacology November 1991, 40 (5) 859-867;

  4. Pellegrini-Giampietro, D E

    1. High efficiency reconstitution of a phencyclidine/MK-801 receptor binding site solubilized from rat forebrain membranes.
      R Haring, D E Pellegrini-Giampietro, S R Zukin, R S Zukin and M A Scheideler
      Molecular Pharmacology November 1991, 40 (5) 666-673;

  5. Philpot, R M

    1. Properties of expressed and native flavin-containing monooxygenases: evidence of multiple forms in rabbit liver and lung.
      M P Lawton, T Kronbach, E F Johnson and R M Philpot
      Molecular Pharmacology November 1991, 40 (5) 692-698;

  6. Putney, J W

    1. Different modes of regulation for receptors activating phospholipase C in the rat pancreatoma cell line AR4-2J.
      F S Menniti, H Takemura, K G Oliver and J W Putney
      Molecular Pharmacology November 1991, 40 (5) 727-733;

R

  1. Ragsdale, D S

    1. Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.
      D S Ragsdale, T Scheuer and W A Catterall
      Molecular Pharmacology November 1991, 40 (5) 756-765;

  2. Ramkumar, V

    1. Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.
      V Ramkumar, M E Olah, K A Jacobson and G L Stiles
      Molecular Pharmacology November 1991, 40 (5) 639-647;

  3. Rampe, D

    1. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
      W Zheng, D Rampe and D J Triggle
      Molecular Pharmacology November 1991, 40 (5) 734-741;

  4. Riou, J F

    1. Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives.
      J F Riou, P Helissey, L Grondard and S Giorgi-Renault
      Molecular Pharmacology November 1991, 40 (5) 699-706;

  5. Roach, M C

    1. Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)-one.
      C M Lin, G J Kang, M C Roach, J B Jiang, D P Hesson, R F Luduena and E Hamel
      Molecular Pharmacology November 1991, 40 (5) 827-832;

  6. Rosenberg, R L

    1. Ethaverine, a derivative of papaverine, inhibits cardiac L-type calcium channels.
      Y Wang and R L Rosenberg
      Molecular Pharmacology November 1991, 40 (5) 750-755;

  7. Rucci, G

    1. Alpha-naphthoflavone acts as an antagonist of 2,3,7, 8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor.
      T A Gasiewicz and G Rucci
      Molecular Pharmacology November 1991, 40 (5) 607-612;

S

  1. Scheideler, M A

    1. High efficiency reconstitution of a phencyclidine/MK-801 receptor binding site solubilized from rat forebrain membranes.
      R Haring, D E Pellegrini-Giampietro, S R Zukin, R S Zukin and M A Scheideler
      Molecular Pharmacology November 1991, 40 (5) 666-673;

  2. Scheuer, T

    1. Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.
      D S Ragsdale, T Scheuer and W A Catterall
      Molecular Pharmacology November 1991, 40 (5) 756-765;

  3. Schweitzer, B I

    1. Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.
      W W Li, J T Lin, B I Schweitzer and J R Bertino
      Molecular Pharmacology November 1991, 40 (5) 854-858;

  4. Schwinn, D A

    1. The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity.
      D A Schwinn, S O Page, J P Middleton, W Lorenz, S B Liggett, K Yamamoto, E G Lapetina, M G Caron, R J Lefkowitz and S Cotecchia
      Molecular Pharmacology November 1991, 40 (5) 619-626;

  5. Semus, S F

    1. Modeling the cannabinoid receptor: a three-dimensional quantitative structure-activity analysis.
      B F Thomas, D R Compton, B R Martin and S F Semus
      Molecular Pharmacology November 1991, 40 (5) 656-665;

  6. Shimada, T

    1. Purification and characterization of human liver microsomal cytochrome P-450 2A6.
      C H Yun, T Shimada and F P Guengerich
      Molecular Pharmacology November 1991, 40 (5) 679-685;

  7. Siemens, I R

    1. Biochemical analysis of solubilized angiotensin II receptors from murine neuroblastoma N1E-115 cells by covalent cross-linking and affinity purification.
      I R Siemens, H J Adler, K Addya, S J Mah and S J Fluharty
      Molecular Pharmacology November 1991, 40 (5) 717-726;

  8. Sommadossi, J P

    1. Metabolism and DNA interaction of 2',3'-didehydro-2',3'-dideoxythymidine in human bone marrow cells.
      Z Zhu, M J Hitchcock and J P Sommadossi
      Molecular Pharmacology November 1991, 40 (5) 838-845;

  9. Stiles, G L

    1. Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.
      V Ramkumar, M E Olah, K A Jacobson and G L Stiles
      Molecular Pharmacology November 1991, 40 (5) 639-647;

  10. Sutherland, R L

    1. Inhibition of DNA binding and transcriptional activity of a nuclear receptor transcription factor by aurothiomalate and other metal ions.
      M L Handel, A deFazio, C K Watts, R O Day and R L Sutherland
      Molecular Pharmacology November 1991, 40 (5) 613-618;

T

  1. Tachikawa, E

    1. Trichosporin-B-III, an alpha-aminoisobutyric acid-containing peptide, causes Ca(2+)-dependent catecholamine secretion from adrenal medullary chromaffin cells.
      E Tachikawa, S Takahashi, K Furumachi, T Kashimoto, A Iida, Y Nagaoka, T Fujita and Y Takaishi
      Molecular Pharmacology November 1991, 40 (5) 790-797;

  2. Takahashi, S

    1. Trichosporin-B-III, an alpha-aminoisobutyric acid-containing peptide, causes Ca(2+)-dependent catecholamine secretion from adrenal medullary chromaffin cells.
      E Tachikawa, S Takahashi, K Furumachi, T Kashimoto, A Iida, Y Nagaoka, T Fujita and Y Takaishi
      Molecular Pharmacology November 1991, 40 (5) 790-797;

  3. Takaishi, Y

    1. Trichosporin-B-III, an alpha-aminoisobutyric acid-containing peptide, causes Ca(2+)-dependent catecholamine secretion from adrenal medullary chromaffin cells.
      E Tachikawa, S Takahashi, K Furumachi, T Kashimoto, A Iida, Y Nagaoka, T Fujita and Y Takaishi
      Molecular Pharmacology November 1991, 40 (5) 790-797;

  4. Takemura, H

    1. Different modes of regulation for receptors activating phospholipase C in the rat pancreatoma cell line AR4-2J.
      F S Menniti, H Takemura, K G Oliver and J W Putney
      Molecular Pharmacology November 1991, 40 (5) 727-733;

  5. Thayer, S A

    1. omega-Conotoxin exerts functionally distinct low and high affinity effects in the neuronal cell line NG108-15.
      J L Werth, L D Hirning and S A Thayer
      Molecular Pharmacology November 1991, 40 (5) 742-749;

  6. Thomas, B F

    1. Modeling the cannabinoid receptor: a three-dimensional quantitative structure-activity analysis.
      B F Thomas, D R Compton, B R Martin and S F Semus
      Molecular Pharmacology November 1991, 40 (5) 656-665;

  7. Triggle, D J

    1. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
      W Zheng, D Rampe and D J Triggle
      Molecular Pharmacology November 1991, 40 (5) 734-741;

  8. Tsai, A L

    1. Prostaglandin H synthase: perturbation of the tyrosyl radical as a probe of anticyclooxygenase agents.
      R J Kulmacz, G Palmer and A L Tsai
      Molecular Pharmacology November 1991, 40 (5) 833-837;

W

  1. Wall, S J

    1. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines.
      S J Wall, R P Yasuda, M Li and B B Wolfe
      Molecular Pharmacology November 1991, 40 (5) 783-789;

  2. Wang, Y

    1. Ethaverine, a derivative of papaverine, inhibits cardiac L-type calcium channels.
      Y Wang and R L Rosenberg
      Molecular Pharmacology November 1991, 40 (5) 750-755;

  3. Watts, C K

    1. Inhibition of DNA binding and transcriptional activity of a nuclear receptor transcription factor by aurothiomalate and other metal ions.
      M L Handel, A deFazio, C K Watts, R O Day and R L Sutherland
      Molecular Pharmacology November 1991, 40 (5) 613-618;

  4. Werth, J L

    1. omega-Conotoxin exerts functionally distinct low and high affinity effects in the neuronal cell line NG108-15.
      J L Werth, L D Hirning and S A Thayer
      Molecular Pharmacology November 1991, 40 (5) 742-749;

  5. Williams, K

    1. Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines.
      K Williams, J L Hanna and P B Molinoff
      Molecular Pharmacology November 1991, 40 (5) 774-782;

  6. Wolfe, B B

    1. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines.
      S J Wall, R P Yasuda, M Li and B B Wolfe
      Molecular Pharmacology November 1991, 40 (5) 783-789;

Y

  1. Yamamoto, K

    1. The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity.
      D A Schwinn, S O Page, J P Middleton, W Lorenz, S B Liggett, K Yamamoto, E G Lapetina, M G Caron, R J Lefkowitz and S Cotecchia
      Molecular Pharmacology November 1991, 40 (5) 619-626;

  2. Yasuda, R P

    1. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines.
      S J Wall, R P Yasuda, M Li and B B Wolfe
      Molecular Pharmacology November 1991, 40 (5) 783-789;

  3. Yun, C H

    1. Purification and characterization of human liver microsomal cytochrome P-450 2A6.
      C H Yun, T Shimada and F P Guengerich
      Molecular Pharmacology November 1991, 40 (5) 679-685;

Z

  1. Zheng, W

    1. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
      W Zheng, D Rampe and D J Triggle
      Molecular Pharmacology November 1991, 40 (5) 734-741;

  2. Zhu, Z

    1. Metabolism and DNA interaction of 2',3'-didehydro-2',3'-dideoxythymidine in human bone marrow cells.
      Z Zhu, M J Hitchcock and J P Sommadossi
      Molecular Pharmacology November 1991, 40 (5) 838-845;

  3. Zukin, R S

    1. High efficiency reconstitution of a phencyclidine/MK-801 receptor binding site solubilized from rat forebrain membranes.
      R Haring, D E Pellegrini-Giampietro, S R Zukin, R S Zukin and M A Scheideler
      Molecular Pharmacology November 1991, 40 (5) 666-673;

  4. Zukin, S R

    1. High efficiency reconstitution of a phencyclidine/MK-801 receptor binding site solubilized from rat forebrain membranes.
      R Haring, D E Pellegrini-Giampietro, S R Zukin, R S Zukin and M A Scheideler
      Molecular Pharmacology November 1991, 40 (5) 666-673;
Back to top

In this issue

Advertisement